Press Releases
Presentations
CHDI 2020: Targeting DNA Damage Response genes with oligonucleotides for therapeutic modulation of HTT somatic instability
In the News
Media contact
Eric Sullivan
Triplet Therapeutics
esullivan@triplettx.com
Eric Sullivan
Triplet Therapeutics
esullivan@triplettx.com